Pharma-Bio Serv (PBSV) Operating Income (2010 - 2026)
Pharma-Bio Serv posted quarterly Operating Income of -$94535.0 for Q1 2026, down 2.54% year-on-year from -$97001.3 in Q1 2025, and up 29.07% on a QoQ basis from -$133272.0 in Q4 2025.
Pharma-Bio Serv (PBSV) has 16 years of Operating Income data on file, last reported at -$94535.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Income fell 2.54% year-over-year to -$94535.0; the trailing twelve-month figure through Jan 2026 stood at -$640006.0 (up 32.02% YoY), and the FY2025 full-year result was -$637662.0, up 50.48% from the prior year.
- Operating Income for Q1 2026 stood at -$94535.0, up from -$133272.0 in the prior quarter.
- Across five years, Operating Income topped out at $460466.0 in Q3 2023 and bottomed at -$438300.0 in Q1 2024.
- The 5-year median for Operating Income is -$92191.0 (2025), against an average of $16033.6.
- The widest annual swing landed in 2022, when Operating Income surged 103.52%; it then sank 233.37% in 2024.
- A 5-year view of Operating Income shows it stood at $168962.0 in 2022, then tumbled by 130.64% to -$51765.0 in 2023, then plunged by 197.75% to -$154130.0 in 2024, then rose by 13.53% to -$133272.0 in 2025, then advanced by 29.07% to -$94535.0 in 2026.
- The last three Operating Income figures came in at -$94535.0 (Q1 2026), -$133272.0 (Q4 2025), and -$313877.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 245.88 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 121.45 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 102.95 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 32.07 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 24.83 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 80.47 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -17.05 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 7.42 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 16.85 Mn |
| 10 | Pharma-Bio Serv | - | - | 722,374.00 | -94,535.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -94,535.00 |
| Oct 31, 2025 | -133,272.00 |
| Jul 31, 2025 | -313,877.00 |
| Apr 30, 2025 | -98,322.00 |
| Jan 31, 2025 | -92,191.00 |
| Oct 31, 2024 | -154,130.00 |
| Jul 31, 2024 | -381,782.00 |
| Apr 30, 2024 | -313,375.00 |
| Jan 31, 2024 | -438,300.00 |
| Oct 31, 2023 | -51,765.00 |
| Jul 31, 2023 | 460,466.00 |
| Apr 30, 2023 | 380,078.00 |
| Jan 31, 2023 | 328,632.00 |
| Oct 31, 2022 | 168,962.00 |
| Jul 31, 2022 | 369,505.00 |
| Apr 30, 2022 | 280,630.00 |
| Jan 31, 2022 | 355,848.00 |
| Oct 31, 2021 | -4.80 Mn |
| Jul 31, 2021 | 360,490.00 |
| Apr 30, 2021 | 264,779.00 |
| Jan 31, 2021 | 319,121.00 |
| Oct 31, 2020 | 151,714.00 |
| Jul 31, 2020 | 816,690.00 |
| Apr 30, 2020 | 720,384.00 |
| Jan 31, 2020 | 536,759.00 |
| Oct 31, 2019 | 426,558.00 |
| Jul 31, 2019 | 360,696.00 |
| Apr 30, 2019 | 476,928.00 |
| Jan 31, 2019 | 471,020.00 |
| Oct 31, 2018 | 497,442.00 |
| Jul 31, 2018 | 721,819.00 |
| Apr 30, 2018 | -8,683.00 |
| Jan 31, 2018 | -2.47 Mn |
| Oct 31, 2017 | 125,001.00 |
| Jul 31, 2017 | -194,254.00 |
| Apr 30, 2017 | -324,568.00 |
| Jan 31, 2017 | -383,997.00 |
| Oct 31, 2016 | -449,758.00 |
| Jul 31, 2016 | -120,786.00 |
| Apr 30, 2016 | 94,637.00 |
| Jan 31, 2016 | 384,148.00 |
| Oct 31, 2015 | 565,586.00 |
| Jul 31, 2015 | 495,322.00 |
| Apr 30, 2013 | 1.75 Mn |
| Jan 31, 2013 | 1.29 Mn |
| Oct 31, 2012 | 1.37 Mn |
| Jul 31, 2012 | 1.57 Mn |
| Apr 30, 2012 | 1.43 Mn |
| Jan 31, 2012 | 1.36 Mn |
| Oct 31, 2011 | 1.03 Mn |
| Jul 31, 2011 | 1.17 Mn |
| Apr 30, 2011 | 736,755.00 |
| Jan 31, 2011 | 517,527.00 |
| Oct 31, 2010 | 277,502.00 |
| Jul 31, 2010 | 204,759.00 |